Ignite Creation Date:
2025-12-25 @ 2:28 AM
Ignite Modification Date:
2026-01-08 @ 11:12 PM
Study NCT ID:
NCT00502034
Status:
COMPLETED
Last Update Posted:
2013-07-10
First Post:
2007-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma.
Sponsor:
Gruppo Oncologico Italiano di Ricerca Clinica
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1994-07
Start Date Type:
None
Primary Completion Date:
2007-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-07-16
First Submit QC Date:
None
Study First Post Date:
2007-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-07-09
Last Update Post Date:
2013-07-10
Last Update Post Date Type:
ESTIMATED